Economic Burden of Chronic Spontaneous Urticaria and Psoriasis: Patients Perspective From Europe & Us

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.1008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria

Bőrgyógyászati és Venerológiai Szemle
2015English

Predictors of BAT Positivity in Chronic Spontaneous Urticaria and Clinical Characteristics of Patients

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

High Prevalence of Mental Disorders and Emotional Distress in Patients With Chronic Spontaneous Urticaria

Acta Dermato-Venereologica
DermatologyMedicine
2011English

Chronic Spontaneous Urticaria and Internal Parasites - A Systematic Review

Allergy: European Journal of Allergy and Clinical Immunology
AllergyImmunology
2015English

Transient Hair Loss in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2017English

Cost of Treatment of Chronic Spontaneous Urticaria in Turkey

Health
2016English

Treatment Refractory Chronic Spontaneous Urticaria Patients Achieves Remission With Low Molecular Weight Heparin

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria

Asim, Allerji, Immunoloji
Respiratory MedicinePulmonaryAllergyImmunology
2018English

Omalizumab Updosing Allows Disease Activity Control in Refractory Patients With Chronic Spontaneous Urticaria

British Journal of Dermatology
DermatologyMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy